Grantclosed🌐 United StatesRFA-EY-21-002
Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Details?
- Posted
- Nov 17, 2021
- Response deadline
- Feb 17, 2022, 12:00 AM UTC
- Type
- Grant
- Category
- 93.867
- Status
- closed
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- RFA-EY-21-002
- Doc Type
- synopsis
- Opp Status
- archived
Finding similar opportunities…
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.
Raw record
{
"id": "336578",
"title": "Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed)",
"agency": "National Institutes of Health",
"number": "RFA-EY-21-002",
"docType": "synopsis",
"cfdaList": [
"93.867"
],
"openDate": "11/17/2021",
"closeDate": "02/17/2022",
"oppStatus": "archived",
"agencyCode": "HHS-NIH11"
}